AJP - GI AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 283: G187-G195, 2002. First published February 27, 2002; doi:10.1152/ajpgi.00331.2001
0193-1857/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/G187    most recent
00331.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Togawa, J.-I.
Right arrow Articles by Sekihara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Togawa, J.-I.
Right arrow Articles by Sekihara, H.
Vol. 283, Issue 1, G187-G195, July 2002

Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance

Jun-Ichi Togawa, Hajime Nagase, Katsuaki Tanaka, Masahiko Inamori, Tadashi Umezawa, Atsushi Nakajima, Makoto Naito, Shinobu Sato, Toshifumi Saito, and Hisahiko Sekihara

Third Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama 236-0004, Japan

Natural immunomodulator lactoferrin is known to exert an anti-inflammatory effect. However, there have been no studies that examine the mode of action of lactoferrin in reducing intestinal damage. We investigated the effect of lactoferrin on a trinitrobenzenesulfonic acid (TNBS)-induced colitis model in rats. Bovine lactoferrin was given once daily through gavage, starting 3 days before (preventive mode) or just after TNBS administration (treatment mode) until death. The distal colon was removed to be examined. Colitis was attenuated by lactoferrin via both modes in a dose-dependent manner, as reflected by improvement in macroscopic and histological scores and myeloperoxidase activity. Lactoferrin caused significant induction of the anti-inflammatory cytokines interleukin (IL)-4 and IL-10, significant reductions in the proinflammatory cytokines tumor necrosis factor-alpha and IL-1beta , and downregulation of the nuclear factor-kappa B pathway. We concluded that lactoferrin exerts a protective effect against colitis in rats via modulation of the immune system and correction of cytokine imbalance. Lactoferrin has potential as a new therapeutic agent for inflammatory bowel disease.

trinitrobenzenesulfonic acid; inflammatory bowel disease; tumor necrosis factor; interleukin; nuclear factor-kappa B


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. S. Wolf, G. Li, A. Varadhachary, K. Petrak, M. Schneyer, D. Li, J. Ongkasuwan, X. Zhang, R. J. Taylor, S. E. Strome, et al.
Oral Lactoferrin Results in T Cell-Dependent Tumor Inhibition of Head and Neck Squamous Cell Carcinoma In vivo
Clin. Cancer Res., March 1, 2007; 13(5): 1601 - 1610.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K.-J. Li, M.-C. Lu, S.-C. Hsieh, C.-H. Wu, H.-S. Yu, C.-Y. Tsai, and C.-L. Yu
Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+T cells and its modulation on Th1/Th2 cytokine production
J. Leukoc. Biol., August 1, 2006; 80(2): 350 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
N. Leon-Sicairos, F. Lopez-Soto, M. Reyes-Lopez, D. Godinez-Vargas, C. Ordaz-Pichardo, and M. de la Garza
Amoebicidal Activity of Milk, Apo-lactoferrin, sIgA and Lysozyme.
Clin. Med. Res., June 1, 2006; 4(2): 106 - 113.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
H. Wakabayashi, N. Takakura, K. Yamauchi, and Y. Tamura
Modulation of Immunity-Related Gene Expression in Small Intestines of Mice by Oral Administration of Lactoferrin
Clin. Vaccine Immunol., February 1, 2006; 13(2): 239 - 245.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online